[HTML][HTML] Management of in-stent restenosis

F Alfonso, JJ Coughlan, D Giacoppo, A Kastrati… - …, 2022 - ncbi.nlm.nih.gov
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

[PDF][PDF] Management of Myocardial Revascularization Failure: An Expert Consensus

GG Stefanini, F Alfonso, E Barbato, RA Byrne… - Trials, 2018 - researchgate.net
Myocardial revascularization represents the most frequently performed therapeutic
intervention worldwide. Current percutaneous and surgical revascularization techniques …

[HTML][HTML] In-stent restenosis characteristics and repeat stenting underexpansion: insights from optical coherence tomography

D Yin, GS Mintz, L Song, Z Chen… - …, 2020 - eurointervention.pcronline.com
Aims: The aim of this study was to use optical coherence tomography (OCT) to predict newly
implanted stent expansion for treatment of in-stent restenosis (ISR). Methods and results …

Current Management of In-Stent Restenosis

D Giacoppo, PM Mazzone, D Capodanno - Journal of Clinical Medicine, 2024 - mdpi.com
In-stent restenosis (ISR) remains the primary cause of target lesion failure following
percutaneous coronary intervention (PCI), resulting in 10-year incidences of target lesion …

[HTML][HTML] Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis: Restenosis characteristics and …

E Xhepa, J Bresha, M Joner, A Hapfelmeier… - …, 2021 - ncbi.nlm.nih.gov
Background Drug-coated balloons (DCB) and drug-eluting stents (DES) represent the
currently recommended treatments for in-stent restenosis (ISR). Optical coherence …

Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions

P Wohlfahrt, D Jenča, V Melenovský… - Frontiers in …, 2022 - frontiersin.org
Background Left ventricular ejection fraction (EF) is an independent predictor of adverse
outcomes after myocardial infarction (MI). However, current data on trajectories and …

Rotational Atherectomy Versus Intravascular Lithotripsy for Calcified In-Stent Restenosis: A Single-Center Study With 1-Year Follow-Up

H Farhat, M Kuzemczak, N Durel, N Caillot… - The American Journal of …, 2023 - Elsevier
Although rotational atherectomy (RA) and intravascular lithotripsy (IVL) have been proved to
be effective for calcified de novo coronary lesions, their use in patients with in-stent …

Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography

WC Huang, HI Teng, HY Chen, CJ Wu, CT Tsai… - International journal of …, 2019 - Elsevier
Background Impaired bioavailability of endothelium-derived nitric oxide (NO) and
endothelial dysfunction may play a pivotal role in the pathogenesis of in-stent restenosis …

[PDF][PDF] 药物洗脱支架术后再狭窄患者支架内新生钙化斑块的发生率及预测因素

张茜, 冯欢欢, 韩燕, 袁晓航, 蒋梦婷, 王威… - 临床心血管病 …, 2023 - lcxxgen.whuhzzs.com
目的: 本研究旨在探索药物洗脱支架术后再狭窄(DES-ISR) 患者支架内新生钙化斑块的发生率及
预测因素. 方法: 回顾性连续入组2010 年1 月—2022 年3 月于解放军总医院接受光学相干断层 …

Efficacy of drug‐coated balloon angioplasty in early versus late occurring drug‐eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and …

T Koch, S Cassese, E Xhepa, K Mayer… - Catheterization and …, 2020 - Wiley Online Library
Background Whether there exist differences concerning clinical outcomes between patients
presenting with early versus late DES‐ISR undergoing treatment with drug‐coated balloons …